Artal Group’s Biohaven BHVN Stock Holding History

Artal Group’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-306,703	Closed	-$10.6M	–	15
2024 Q2	$10.6M	Buy	+306,703	New	+$12.1M	0.27%	39
2023 Q1	–	Sell	-500,000	Closed	-$6.94M	–	123
2022 Q4	$6.94M	Buy	+500,000	New	+$7.06M	0.39%	53

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RP Management New York $139M AUM 37.98% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Artal Group's BHVN Position: Q3 2024 in Review

Artal Group sold out of Biohaven (BHVN) in Q3 2024, closing a stake of 306,703 shares — an estimated $10.6M sold.

Artal Group first reported a position in BHVN in Q4 2022 and held it in 2 quarters. The position peaked at $10.6M in Q2 2024. 254 funds tracked by Wall St. Rank hold BHVN as of Q3 2024.

Artal Group reported no remaining Biohaven position as of Q3 2024 after selling out during the quarter.
Artal Group sold 306,703 Biohaven shares in Q3 2024, an estimated $10.6M.
Artal Group first reported a position in Biohaven in Q4 2022 and held it in 2 quarters.
Artal Group's Biohaven position peaked at $10.6M in Q2 2024.
254 funds tracked by Wall St. Rank held Biohaven as of Q3 2024.

Based on Artal Group's 13F filing for Q3 2024, filed 13 Nov 2024.